Drug Expiration Date Rationale Requested By Waxman
This article was originally published in The Tan Sheet
Executive Summary
Data on FDA's expiration date policies and safety/ effectiveness standards for OTC and Rx drugs are requested by Rep. Henry Waxman (D-Calif.) in a May 19 letter to FDA.
You may also be interested in...
Drug Shelf Life Effect On Cost Uncertain, AMA Report Finds
Additional research is needed to determine whether longer drug product shelf lives would lower drug costs, the American Medical Association Council on Scientific Affairs says in a report prepared for the AMA House of Delegates meeting in Chicago June 17-21.
Drug Shelf Life Effect On Cost Uncertain, AMA Report Finds
Additional research is needed to determine whether longer drug product shelf lives would lower drug costs, the American Medical Association Council on Scientific Affairs says in a report prepared for the AMA House of Delegates meeting in Chicago June 17-21.
Drug Shelf Life Effect On Cost Uncertain, AMA Report Finds
Additional research is needed to determine whether longer drug product shelf lives would lower drug costs, the American Medical Association Council on Scientific Affairs says in a report prepared for the AMA House of Delegates meeting in Chicago June 17-21.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: